Search for: "Sanofi-Aventis US LLC"
Results 61 - 80
of 84
Sorted by Relevance
|
Sort by Date
27 Jun 2012, 9:41 am
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
10 Aug 2012, 5:00 am
Sanofi-Aventis U.S. [read post]
9 Aug 2021, 2:22 pm
Sanofi-Aventis U.S. [read post]
14 Dec 2007, 1:00 am
: (IAM), (Spicy IP),ItalyThe objective technical opinion of AIPPI Italy: (CATCH US IF YOU CAN!!!) [read post]
16 Jan 2009, 7:00 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
29 May 2009, 1:28 am
Aventis Pharmaceutical, a subsidiary of Sanofi-Aventis U.S., has agreed to pay the United States $95.5 million to settle allegations that it violated the False Claims Act by misreporting drug prices to skirt its Medicaid rebate obligations. [read post]
2 Dec 2011, 2:00 pm
Sanofi-Aventis United States LLC, 2011 WL 3666595, at *3 (W.D. [read post]
9 Jun 2012, 5:13 am
” The former Sanofi-Aventis chemist, Yuan Li, who pled guilty in January to passing trade secrets to a Chinese company was sentenced on May 8, 2012 to 18 months in prison and ordered to pay $131,000 in restitution. [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay… [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz… [read post]
23 Aug 2008, 1:23 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
24 Nov 2023, 6:08 pm
Greene’s Energy Group, LLC, 138 S. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
11 Jul 2008, 4:30 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
31 Dec 2015, 5:12 am
Sanofi-Aventis United States LLP, 806 F.3d 71 (2d Cir. 2015). [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem… [read post]
7 Sep 2012, 3:23 pm
a PMA device that restricts the ability of the stomach to expand, used as a last-ditch weight control measure in cases of morbid obesity.Ali involves several preemption issues, and is also good on TwIqbal and the Virginia Consumer Protection Act. [read post]
15 Sep 2011, 5:00 am
Sanofi-Aventis U.S. [read post]
17 Oct 2013, 5:00 am
This one gets less play than the others – perhaps because of how courts sometimes use “communication” to get around it in non-prescription medical product cases (more on that to come), or sometimes because plaintiffs might use the same testimony to claim medical malpractice.But prescriber failure to read can be a powerful tool. [read post]
